Cargando…

Cohesive Polydensified Matrix(®) hyaluronic acid volumizer injected for cheek augmentation has additional positive effect on nasolabial folds

PURPOSE: Cohesive Polydensified Matrix(®) hyaluronic acid (CPM-HA) volumizer has been used successfully for several years to reverse biometric volume loss during facial aging. This observational study explored the additive effect on nasolabial folds when CPM-HA volumizer is injected into the neighbo...

Descripción completa

Detalles Bibliográficos
Autores principales: Gauglitz, Gerd, Steckmeier, Stephanie, Pötschke, Julian, Schwaiger, Hannah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733916/
https://www.ncbi.nlm.nih.gov/pubmed/29276401
http://dx.doi.org/10.2147/CCID.S141906
_version_ 1783286968568774656
author Gauglitz, Gerd
Steckmeier, Stephanie
Pötschke, Julian
Schwaiger, Hannah
author_facet Gauglitz, Gerd
Steckmeier, Stephanie
Pötschke, Julian
Schwaiger, Hannah
author_sort Gauglitz, Gerd
collection PubMed
description PURPOSE: Cohesive Polydensified Matrix(®) hyaluronic acid (CPM-HA) volumizer has been used successfully for several years to reverse biometric volume loss during facial aging. This observational study explored the additive effect on nasolabial folds when CPM-HA volumizer is injected into the neighboring cheek area. PATIENTS AND METHODS: In this open-label, prospective, postmarketing noninterventional study, 18 adult patients seeking esthetic enhancement of the lateral cheek hollows and cheekbone area were injected with CPM-HA volumizer integrated with lidocaine (CPM-HA-VL) in the upper or lower cheek area. Safety and performance of CPM-HA-VL up to 12 months after injection with follow-up visits at week 4 and month 3, 6, and 12 were assessed. The primary endpoint was improvement of cheek fullness on the validated Merz Aesthetics Scales. Additionally, changes in nasolabial folds were quantified using a phaseshift rapid in vivo measurement of skin optical three-dimensional (3D) in vivo measurement device. RESULTS: Patients (94.4% female, median age 52 years, age range 39–69 years) were injected with a mean volume of 2.5±1.1 mL CPM-HA-VL per side. Immediately after injection, mean severity for upper and lower cheek fullness assessed on the validated MAS improved from 2.5±0.6 and 2.8±0.5, respectively, to 1.0±0.0, and remained unchanged through month 12. Improvement in relation to baseline was attested on the Global Aesthetics Improvement Scale for all assessments. Compared with baseline, the following assessments offered a statistical significance in the reduction of wrinkle depth of nasolabial folds (maximum depth reduction by 30.4% at 3 months) according to optical 3D in vivo measurements. Pain during injection was minimal and abated within 30 minutes. Treatment was well tolerated and led to great patient satisfaction. CONCLUSION: CPM-HA-VL injected into the upper and lower cheeks led to long-lasting satisfactory cosmetic results in cheek augmentation as well as in reducing depth of nasolabial folds adjacent to the injection site.
format Online
Article
Text
id pubmed-5733916
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-57339162017-12-22 Cohesive Polydensified Matrix(®) hyaluronic acid volumizer injected for cheek augmentation has additional positive effect on nasolabial folds Gauglitz, Gerd Steckmeier, Stephanie Pötschke, Julian Schwaiger, Hannah Clin Cosmet Investig Dermatol Original Research PURPOSE: Cohesive Polydensified Matrix(®) hyaluronic acid (CPM-HA) volumizer has been used successfully for several years to reverse biometric volume loss during facial aging. This observational study explored the additive effect on nasolabial folds when CPM-HA volumizer is injected into the neighboring cheek area. PATIENTS AND METHODS: In this open-label, prospective, postmarketing noninterventional study, 18 adult patients seeking esthetic enhancement of the lateral cheek hollows and cheekbone area were injected with CPM-HA volumizer integrated with lidocaine (CPM-HA-VL) in the upper or lower cheek area. Safety and performance of CPM-HA-VL up to 12 months after injection with follow-up visits at week 4 and month 3, 6, and 12 were assessed. The primary endpoint was improvement of cheek fullness on the validated Merz Aesthetics Scales. Additionally, changes in nasolabial folds were quantified using a phaseshift rapid in vivo measurement of skin optical three-dimensional (3D) in vivo measurement device. RESULTS: Patients (94.4% female, median age 52 years, age range 39–69 years) were injected with a mean volume of 2.5±1.1 mL CPM-HA-VL per side. Immediately after injection, mean severity for upper and lower cheek fullness assessed on the validated MAS improved from 2.5±0.6 and 2.8±0.5, respectively, to 1.0±0.0, and remained unchanged through month 12. Improvement in relation to baseline was attested on the Global Aesthetics Improvement Scale for all assessments. Compared with baseline, the following assessments offered a statistical significance in the reduction of wrinkle depth of nasolabial folds (maximum depth reduction by 30.4% at 3 months) according to optical 3D in vivo measurements. Pain during injection was minimal and abated within 30 minutes. Treatment was well tolerated and led to great patient satisfaction. CONCLUSION: CPM-HA-VL injected into the upper and lower cheeks led to long-lasting satisfactory cosmetic results in cheek augmentation as well as in reducing depth of nasolabial folds adjacent to the injection site. Dove Medical Press 2017-12-14 /pmc/articles/PMC5733916/ /pubmed/29276401 http://dx.doi.org/10.2147/CCID.S141906 Text en © 2017 Gauglitz et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Gauglitz, Gerd
Steckmeier, Stephanie
Pötschke, Julian
Schwaiger, Hannah
Cohesive Polydensified Matrix(®) hyaluronic acid volumizer injected for cheek augmentation has additional positive effect on nasolabial folds
title Cohesive Polydensified Matrix(®) hyaluronic acid volumizer injected for cheek augmentation has additional positive effect on nasolabial folds
title_full Cohesive Polydensified Matrix(®) hyaluronic acid volumizer injected for cheek augmentation has additional positive effect on nasolabial folds
title_fullStr Cohesive Polydensified Matrix(®) hyaluronic acid volumizer injected for cheek augmentation has additional positive effect on nasolabial folds
title_full_unstemmed Cohesive Polydensified Matrix(®) hyaluronic acid volumizer injected for cheek augmentation has additional positive effect on nasolabial folds
title_short Cohesive Polydensified Matrix(®) hyaluronic acid volumizer injected for cheek augmentation has additional positive effect on nasolabial folds
title_sort cohesive polydensified matrix(®) hyaluronic acid volumizer injected for cheek augmentation has additional positive effect on nasolabial folds
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733916/
https://www.ncbi.nlm.nih.gov/pubmed/29276401
http://dx.doi.org/10.2147/CCID.S141906
work_keys_str_mv AT gauglitzgerd cohesivepolydensifiedmatrixhyaluronicacidvolumizerinjectedforcheekaugmentationhasadditionalpositiveeffectonnasolabialfolds
AT steckmeierstephanie cohesivepolydensifiedmatrixhyaluronicacidvolumizerinjectedforcheekaugmentationhasadditionalpositiveeffectonnasolabialfolds
AT potschkejulian cohesivepolydensifiedmatrixhyaluronicacidvolumizerinjectedforcheekaugmentationhasadditionalpositiveeffectonnasolabialfolds
AT schwaigerhannah cohesivepolydensifiedmatrixhyaluronicacidvolumizerinjectedforcheekaugmentationhasadditionalpositiveeffectonnasolabialfolds